BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, July 17, 2026
Home » Authors » John Fox

Articles by John Fox

Ketamine discovery may yield fast-acting antidepressants

March 5, 2018
By John Fox

Ketamine discovery may yield fast-acting antidepressants

March 2, 2018
By John Fox
HONG KONG – A Chinese study has shown for the first time that the powerful antidepressant effects of ketamine are due to blockade of rapid neuronal firing in the brain's lateral habenula (LHb) region. Such blockade was found to disinhibit reward centers and relieve depressive symptoms rapidly in animal models.
Read More

Nanorobots deliver blood-curdling cancer therapy

Feb. 28, 2018
By John Fox
HONG KONG – Researchers led by the National Center for Nano-science Technology (NCNST), Chinese Academy of Sciences, have developed a DNA-based nanorobot and shown in mammals that it is a safe and effective means of delivering targeted cancer treatment in response to a molecular trigger.
Read More

Organ on a chip provides insight into hepatitis B virus

Feb. 28, 2018
By John Fox
HONG KONG – Scientists at Imperial College London are testing how the hepatitis B virus (HBV) interacts with the liver using new organ on a chip technology, which could lead to the future development of new treatments for HBV and other diseases.
Read More

Nanorobots deliver blood-curdling cancer therapy

Feb. 23, 2018
By John Fox

Nanorobots deliver blood-curdling cancer therapy

Feb. 23, 2018
By John Fox
Researchers led by the National Center for Nano-science Technology (NCNST), Chinese Academy of Sciences, have developed a DNA-based nanorobot and shown in mammals that it is a safe and effective means of delivering targeted cancer treatment in response to a molecular trigger.
Read More

Organ on a chip gives insight into hepatitis B virus

Feb. 22, 2018
By John Fox

Organ on a chip provides insight into hepatitis B virus

Feb. 22, 2018
By John Fox
Scientists at Imperial College London are testing how the hepatitis B virus (HBV) interacts with the liver using new organ on a chip technology, which could lead to the future development of new treatments for HBV and other diseases.
Read More

GWAS in Chinese population implicates immune system in Alzheimer's disease

Feb. 20, 2018
By John Fox

GWAS in Chinese population implicates immune system in Alzheimer's disease

Feb. 15, 2018
By John Fox
A study has identified common genetic variants in the Chinese population contributing to the risk of developing Alzheimer's disease (AD) that possibly exert functional effects through the immune system, which could have important implications for AD management.
Read More
Previous 1 2 … 24 25 26 27 28 29 30 31 32 … 68 69 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 17, 2026.
  • AI-generated  illustration of a neuron with tau protein aggregation

    AAIC 2026: Age of amyloid is being joined by time of tau

    BioWorld
    The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
  • Senior medical exam

    Celia trial: data strong, analysts skeptical

    BioWorld
    Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 14, 2026
  • Illustration of human brain and dna

    Voyager’s gene therapy reduces tau levels in AD models

    BioWorld Science
    At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
    • Videos
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing